Screener/Healthcare/Biotechnology

MDGL

Madrigal Pharmaceuticals, Inc.NASDAQ
$446.32-0.91 (-0.20%)
Large CapHealthcareFastest Growing
$265.00
$615.00
$437.05
$449.13
EPS (TTM)$-12.83
P/E Ratio—
Dividend Yield—
Market Cap$10.42B
Volume112K
Prev Close$447.72
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$321.1M-$58.6M$-2.53—-18.2%
Q3 '25$287.3M-$114.2M$-5.08—-39.8%
Q2 '25$212.8M-$42.3M$-1.90—-19.9%
Q1 '25$137.3M-$73.2M$-3.3296.7%-53.4%
Q4 '24$103.3M-$59.4M$-2.59—-57.5%
Q3 '24$62.2M-$107.0M$-4.92—-172.0%
Q2 '24$14.6M-$152.0M$-7.10—-1038.2%
Q1 '24$0-$147.5M$-7.38——
Get Your Daily Market Recap